Takeda Pharmaceutical (TAK) Shares Outstanding (Weighted Average): 2019-2025

  • Takeda Pharmaceutical's Shares Outstanding (Weighted Average) rose 1.04% to $1.6 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $1.6 billion, marking a year-over-year increase of 1.04%. This contributed to the annual value of $1.6 billion for FY2025, which is 1.04% up from last year.
  • According to the latest figures from Q1 2025, Takeda Pharmaceutical's Shares Outstanding (Weighted Average) is $1.6 billion, which was up 1.04% from $1.6 billion recorded in Q1 2024.
  • Over the past 5 years, Takeda Pharmaceutical's Shares Outstanding (Weighted Average) peaked at $1.6 billion during Q1 2025, and registered a low of $1.6 billion during Q1 2023.
  • In the last 3 years, Takeda Pharmaceutical's Shares Outstanding (Weighted Average) had a median value of $1.6 billion in 2024 and averaged $1.6 billion.
  • Per our database at Business Quant, Takeda Pharmaceutical's Shares Outstanding (Weighted Average) declined by 0.83% in 2023 and then climbed by 1.20% in 2024.
  • Quarterly analysis of 5 years shows Takeda Pharmaceutical's Shares Outstanding (Weighted Average) stood at $1.6 billion in 2021, then climbed by 0.36% to $1.6 billion in 2022, then decreased by 0.83% to $1.6 billion in 2023, then grew by 1.20% to $1.6 billion in 2024, then climbed by 1.04% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q1 2025, $1.6 billion for Q1 2024, and $1.6 billion during Q1 2023.